The first common genetic factor identified for pediatric asthma by genome-wide association is the chromosome 17q21 locus, harbouring the ORMDL3 gene. ORMDL3 is involved in facilitation of endoplasmic reticulum-mediated inflammatory responses, believed to underlie its asthma association. We investigated associations between the rs7216389 polymorphism in the 17q21 locus affecting ORMDL3 expression and the risk for recurrent wheeze and interactions with exposure to tobacco smoke and furred pets during pregnancy and infancy using a birth cohort of 101 042 infants. Rs7216389 was significantly associated with recurrent wheeze risk among 18-month-old infants. There was a 1.35-fold higher risk of recurrent wheeze among homozygous variant allele carriers compared with homozygous wild-type allele carriers. There was significant interaction between rs7216389 and domestic furred pets, with a positive association between pets and wheeze among homozygous wild-type carriers and a negative association among homozygous variant allele carriers. There was no interaction between rs7216389 and tobacco smoke exposure.
Introduction
Wheezing disorders are common in childhood, and a subset of children with early onset wheeze continue to wheeze persistently beyond early years. 1 A recent genome-wide association study of 317 000 single-nucleotide polymorphisms found a strong association between single-nucleotide polymorphisms at the 17q21 locus and childhood asthma, 2 supported by subsequent studies. [3] [4] [5] The rs7216389 single-nucleotide polymorphism showed the strongest association with childhood asthma and transcription levels of ORMDL3.
2
ORMDL3 belongs to the ORMDL family that encodes transmembrane proteins in the endoplasmic reticulum 6 and has been found to alter endoplasmic reticulummediated Ca 2 þ homeostasis, facilitating the unfolded protein response, considered as an endogenous inducer of inflammation. 7 Variants at the 17q21 locus have shown modifying effects on associations between early onset asthma and tobacco smoke exposure, suggesting that gene-environment interactions are important. 3 Early exposure to furred pets might be protective against wheezing symptoms and asthma, although exposure-response relationships have been inconsistent and reverse causality with avoidance behaviour cannot be excluded. 8 Inconsistency could also be genetically determined. In this sense, the rs7216389 polymorphism involved in inflammatory regulation and risk of wheeze and asthma, but probably not atopy, 4 would be an interesting candidate.
We tested the relationship between the rs7216389 variant and recurrent wheeze in the first 18 months of life, and investigated the novel hypothesis that this variant affects associations between risk of wheeze and pet keeping, as well as tobacco smoke exposure.
Methods
The case-control study nested in the Danish National Birth Cohort (DNBC) has previously been described. 9 Between 1997 and 2002, 101 042 pregnant women were recruited. Interviews were conducted at gestational weeks 12 and 30 and at ages 6 and 18 months of the child. Interviews included questions regarding wheeze, atopic dermatitis, smoking habits during pregnancy, postnatal exposure to environmental tobacco smoke, domestic furred pets and parental asthma (online Supplementary Table S1 ). At the 18-month interview, the mother was asked whether the child had ever had wheeze episodes and whether the child had physiciandiagnosed asthmatic bronchitis or asthma. If the mother answered yes to at least one question, she was questioned regarding wheeze episodes since the previous interview. 'Recurrent wheeze' defined as at least four wheeze episodes was used to identify our cases. 10, 11 We used this definition because it is difficult to diagnose asthma in infants, no international consensus is available and the strategy of the individual physician can influence diagnose. 1 Participants were selected among the DNBC individuals according to the following criteria: expected delivery within Greater Copenhagen, wheeze episodes at 18 months of age and availability of blood sample from the child (11 942 participants). Among these individuals, we identified 1111 cases with recurrent wheeze and 734 random control children with no wheeze episodes within sex-defined strata. The Danish Ethical Committee approved the study.
DNA was extracted from filter-paper blood spots by alkaline lysis extraction (Extract-N-Amp; Sigma-Aldrich, Brøndby, Denmark) and whole genome amplified for single-nucleotide polymorphism determination as previously described. 9 Rs7216389 was genotyped by PCR, followed by end-point readings on an ABI-7700 (Applied Biosystems, Naerum, Denmark). Controls were included in each, run and 10% of samples were genotyped twice with identical results. Five-microlitre reaction mixtures contained B20 ng amplified DNA, probes and primers in 1 Â TaqMan 0 -VIC-AAACACGCATGGAC-3 0 -MGB. Odds ratios, for recurrent wheeze were estimated by logistic regression (GENMOD in SAS 9.1, SAS-Institute Inc., Cary, NC, USA) stratified by sex. Two-sided 95% confidence intervals were based on Wald's tests. We estimated odds ratio for the heterozygous and the homozygous variant, respectively, compared with the homozygous wild type. A trend test where the odds ratio was assumed to increase (or decrease) log linearly with number of variant type alleles was conducted. The power to detect a trend in risk corresponding to 20% per variant allele was 78% as calculated by Armitage's test for trend. The frequency distribution of rs7216389 among controls was in Hardy-Weinberg equilibrium.
Effects of pet keeping and tobacco smoke were analysed by estimating risk of recurrent wheeze among exposed individuals compared with non-exposed individuals for each genotype separately. We tested whether the effect of exposure was the same for the three genotypes.
All statistical analyses were conducted including (i) all children and (ii) after restricting data to children with and without physician-diagnosed atopic dermatitis and/ or parental asthma.
Results
The distribution of cases and controls according to gender, wheeze episodes, physician-diagnosed asthma and atopic dermatitis, parental smoking and domestic furred pets have been described previously 9 (online, Supplementary Table S1 ).
We found a statistically significant association between rs7216389 and risk of recurrent wheeze, with a 1.35-fold (95% confidence interval: 1.04-1.76) higher risk among variant allele carriers compared with homozygous wildtype carriers. Analyses restricted to children with and without physician-diagnosed atopic dermatitis and/or parental asthma resulted in, respectively, slightly higher and slightly lower estimates among the variant carriers, compared with the analysis including all children (Table 1 ). There were no statistically significant interactions between the rs7216389 polymorphism and smoking in relation to risk of recurrent wheeze ( Table 2) .
The main effect of furred pets on recurrent wheeze was not significant (Table 2 ). There was interaction between rs7216389 and domestic furred pets when the child was 18 months on risk of recurrent wheeze. The association was positive among homozygous wild-type carriers and negative among homozygous variant allele carriers. A stronger interaction was observed after restriction to children with physician-diagnosed atopic dermatitis and/or parental asthma ( Table 2 ).
Discussion
In this study, Rs7216389 was significantly associated with recurrent wheeze risk among 18-month-old infants. There was significant interaction between rs7216389 and domestic furred pets, with a positive association between pets and wheeze among homozygous wild-type carriers and a negative association among homozygous Infant wheeze, ORMDL3 and furred petsvariant allele carriers. There was no interaction between rs7216389 and tobacco smoke exposure. Identification of the subset of children who will develop asthma later in life could facilitate early intervention, and genetic markers could be an important part of early identification. Rs7216389 has been significantly associated with childhood asthma 2 and wheeze. 4 Here, we replicate this in infants, indicating that genetic variants regulating ORMDL3 expression are determinants of susceptibility, even in early childhood. The risk of recurrent wheezing associated with the variant allele was present among children of parents with and without asthma, confirming that the variant is associated with wheezing and asthma but not atopy. 4 The association with rs7216389 (and other 17q12 locus variants) and asthma onset has been reported to be enhanced by early tobacco smoke exposure. 3, 12 Despite finding a strong association between prenatal and postnatal exposure to tobacco smoke and wheezing, we observed no interaction with the rs7216389 genotype, indicating independence between the variant and tobacco smoke exposure. Parents of a child with the variant are more likely to have the variant with resulting asthma and thus less likely to smoke, causing some selection Effects of pet keeping and tobacco smoke were analysed by estimating risk of recurrent wheeze among exposed individuals compared with non-exposed individuals for each genotype separately and testing whether the effect of exposure was the same for the three genotypes. bias diluting such interactions. Further work is needed in this area. It is uncertain whether pet keeping protects against or promotes wheeze and asthma in children. A recent review concluded that early childhood exposure to dogs or cats did not influence the development of asthma and wheezing symptoms up to school age. 8 We found that the rs7216389 variant affected the association between pet keeping and risk of wheeze, suggesting that the inconsistent exposure-response relationships might be partly related to genetic variations in inflammatory pathways. We found that children from homes with furred pets were at increased risk of wheeze if they carried the CC genotype, whereas for TT carriers the presence of pets decreased the risk with borderline statistical significance. This could indicate that early exposure to furred pets has a protective effect in relation to development of wheeze among carriers of the rs7216389 variant. This interaction was particularly expressed among children with parental asthma and/or physician-diagnosed atopic dermatitis. We found no difference or change in pet keeping in the period from gestational week 12 until 18 months after delivery, either among cases or controls, or among children with atopy and/or parental asthma. This suggests that the possible protective effect of pets among TT carriers is real and not due to avoidance behaviour, and indicates that inconsistent results of earlier studies could be genetically determined.
The risk of recurrent wheeze from 6 to 18 months of age was registered subjectively and retrospectively in this study, which can be associated with uncertainties. Wheeze can be atopic or non-atopic, and is it possible that the rs7216389 polymorphism is only a risk factor in one of these types, which would weaken associations and interactions. The reporting of exposure to tobacco smoke and pet keeping when the child was 18 months of age could be associated with recall bias and/or avoidance behaviour. In contrast, information on tobacco smoke exposure and domestic pets during pregnancy was collected before any wheeze episodes appeared. In the present nested case-control study, both cases and controls were selected from the same birth cohort, minimizing selection bias.
In conclusion, rs7216389 is associated with infant wheeze and interacts with exposure to furred pets.
